Clinical Trial Update: Efficacy and Safety of Memantine Hydrochloride in Enhancing the Cognitive Abilities of Young Adults With Down Syndrome [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating memantine hydrochloride for cognitive enhancement in young adults with Down syndrome; results were posted in 2013.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Down Syndrome

Drugs mentioned

• Namenda (memantine)

Snippet

Sponsor: University of Colorado, Denver | Conditions: Down Syndrome | Phase 4 | Status: COMPLETED | Results posted: 2013-02-01